Skip to main content
HERAMED LIMITED logo

HERAMED LIMITED — Investor Relations & Filings

Ticker · HMD ISIN · AU0000028367 LEI · 875500WOB41XBFTTJ477 ASX Manufacturing
Filings indexed 524 across all filing types
Latest filing 2021-02-09 Capital/Financing Update
Country AU Australia
Listing ASX HMD

About HERAMED LIMITED

https://hera-med.com/

HeraMED Limited is a medical technology company specializing in the development and commercialization of digital health solutions for maternity care. The company focuses on providing remote monitoring tools that bridge the gap between expectant mothers and healthcare providers. Its flagship product, HeraBEAT, is a medical-grade, smartphone-based fetal heart rate monitor designed for home use, allowing for accurate and reliable monitoring of fetal well-being. This hardware is integrated into the HeraCARE platform, a comprehensive digital maternity care solution that enables remote data management, personalized care plans, and seamless communication between patients and clinicians. By leveraging cloud-based technology and advanced sensors, the company aims to enhance prenatal care, improve clinical outcomes, and offer peace of mind through continuous, data-driven insights throughout the pregnancy journey.

Recent filings

Filing Released Lang Actions
Appendix 2A & Cleansing Notice 16 pages 393.5KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the type of securities to be quoted, and references to previous announcements such as Appendix 3B. This type of document is a regulatory announcement related to capital markets activity, specifically the listing or quotation of new securities. It is not a financial report, earnings release, or management discussion. It is also not a report publication announcement but a formal regulatory filing to the exchange. Therefore, the most appropriate classification is Capital/Financing Update (CAP), as it relates to updates on company fundraising, financing activities, or capital structure changes.
2021-02-09 English
Israel's Largest Healthcare Provider Begins Pilot Study 3 pages 159.2KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Sheba Medical Centre in Israel has initiated an operational pilot study using HeraMED's HeraBEAT device and HeraCARE platform. It describes the pilot's stages, the hospital's background, and includes quotes from company executives. There is no financial data, regulatory filing references, or detailed report content. The document is an announcement of a pilot study and partnership, not a financial report, regulatory filing, or other specific filing type. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or others related to financial or governance disclosures. Therefore, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2021-02-07 English
Completion of AUD 2.3M Placement 2 pages 166.8KB
Capital/Financing Update Classification · 100% confidence The document is an ASX announcement dated 4 February 2021 regarding the completion of a AUD $2.3 million placement by HeraMED Limited. It details the amount raised, the number of shares issued, the issue price, discounts, and the use of proceeds. It also mentions the lead manager and fees. The document is a formal announcement of a capital raising event (placement) and does not contain financial statements or detailed financial performance data. It is not a full report but an update on financing activity. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 3422 characters, which is consistent with an announcement rather than a full report.
2021-02-03 English
Proposed issue of Securities - HMD 7 pages 33.1KB
Capital/Financing Update Classification · 100% confidence The document is an announcement from HERAMED LIMITED regarding a proposed issue of securities, including details about the number and type of securities, issue price, approval conditions, and timetable. It is structured as a formal notification to the ASX (Australian Securities Exchange) about a placement or other type of securities issuance. There are no financial statements, management discussion, or detailed financial results included. The content focuses on the capital raising activity and compliance with listing rules. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a report publication notice, but a substantive update on financing activities.
2021-02-03 English
Proposed issue of Securities - HMD 6 pages 30.0KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Proposed issue of securities' and contains detailed information about a new securities issuance by HERAMED LIMITED, including the type of securities (unlisted options), number of securities, issue price, proposed issue date, and conditions such as security holder approval. It references ASX Listing Rules and placement details. There is no financial performance data, earnings information, or management discussion. The document is an announcement about a capital raising activity, specifically a placement or other type of securities issue. This fits the category of Capital/Financing Update (CAP). The document length is 8832 characters, which is substantive and contains detailed information about the proposed issue, not just a brief notice or a report publication announcement. Therefore, the correct classification is CAP with high confidence.
2021-02-03 English
Trading Halt 2 pages 568.2KB
Capital/Financing Update Classification · 95% confidence The document is a market announcement from HeraMED Limited regarding a trading halt requested by the company. The text explicitly states that the trading halt is requested to consider, plan, and execute a capital raising. There is no financial data, report, or detailed analysis present. The document is short (2115 characters) and serves as an announcement of a trading halt related to capital raising activities, not the capital raising update itself. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to financing activities and capital structure changes.
2021-02-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.